Creso Pharma Signs LOI With ImpActive For Further Growth

Creso Pharma (ASX: CPH) this morning announced that it has signed a non-binding letter of intent with that of ImpACTIVE Holdings. The LOI outlines the distribution of a suite of hemp CBD based products, CannaDOL and cannaQIX, in both Canada and the United States.

The arrangement will see both of Creso’s hemp based CBD products meant for human consumption distributed by ImpActive, which is a Canadian firm focused on reducing muscle and joint inflammation, particularly as they related to sports injuries. ImpActive itself has developed a number of CBD products focused on removing the use of narcotics or prescription pharmaceuticals for such injuries.

Under the terms of the non-binding letter of intent, both Creso and ImpActive have agreed to enter a formal commercial agreement by April 1, 2021. The commercial agreement is to determine the terms under which both CannaDOL and cannaQIX will be distributed, with Creso also to become an authorized distributor of ImpActive’s CBD based roll on products in Switzerland and Europe.

“We are very proud to enter the sports and recreational market with such a high calibre partner as ImpACTIVE. This LOI is important for Creso Pharma, as it further broadens our international footprint and provides another large market opportunity.”

Jorge Wernli, Commercial Director of Creso Pharma

The initial term of the arrangement is currently pegged at one year, with an automatic renewal for a second year.

Creso Pharma last traded at $0.20 on the ASX.


FULL DISCLOSURE: Creso Pharma is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Creso Pharma on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Silver’s Finally Breaking the System | Keith Neumeyer – First Majestic

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

Recommended

Steadright To Conduct Multi-Phased Exploration At Historic Goundafa Polymetallic Mine

Goliath Resources Drills 10.72 g/t Gold Over 7.83 Metres At Surebet

Related News

Creso Pharma To Merge With Red Light Holland, Creating The HighBrid Lab

Creso Pharma (ASX: CPH) this morning announced that it is set to merge with that...

Wednesday, June 16, 2021, 09:05:59 AM

US Cannabis: How Will New York Play Out? – The Daily Dive Featuring Bruce Linton

Joining back on the Daily Dive is Bruce Linton, founder and former CEO of Canopy...

Tuesday, September 28, 2021, 01:30:00 PM

Creso’s Canadian Subsidiary Sees $494,000 In Additional Orders

Creso Pharma (ASX: CPH) this morning announced that its Canadian subsidiary, Mernova Medicinal, has obtained...

Wednesday, February 17, 2021, 10:16:02 AM

Mernova: Creso Pharm’s Licensed Cannabis Producer – The Daily Dive feat Jack Yu

Today on the Daily Dive, we sit down with Jack Yu, managing director of Mernova...

Thursday, February 11, 2021, 01:30:00 PM

Creso Pharma Positions Itself For Changing Australian CBD Regulations

Creso Pharma (ASX: CPH) this morning welcomed the advent of changing Australian laws as they...

Monday, February 1, 2021, 07:20:34 AM